Mode
Text Size
Log in / Sign up

Hair follicle-derived epithelial sheet transplantation shows repigmentation in stable vitiligo patientsCould hair follicles help restore skin color in vitiligo?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Preliminary vitiligo repigmentation data lacks study details and quantification.

A study of unspecified design and phase examined hair follicle-derived epithelial sheet (HFES) transplantation in patients with stable vitiligo. The intervention involved transplanting HFES to depigmented areas. The setting, sample size, comparator treatment, and follow-up duration were not reported.

The main finding was that transplantation resulted in skin repigmentation. No quantitative data on effect size, absolute numbers, statistical significance, or direction of effect were provided. The primary outcome measure was not specified, and no secondary outcomes were reported.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. The study had several limitations: the evidence is incomplete due to missing methodological details, sample size, and quantitative results. Funding sources and conflicts of interest were also not reported.

While the authors suggest this technology provides a novel therapeutic option for vitiligo management, the current evidence is insufficient to assess its efficacy or safety profile. Clinicians should interpret these findings as very preliminary and await results from well-designed, controlled clinical trials with reported outcomes and safety monitoring.

Imagine a treatment for vitiligo that uses a part of your own body to help restore your skin's natural color. That's the idea behind a new procedure where doctors transplant a thin sheet of cells taken from a patient's hair follicles onto areas of skin that have lost pigment. In patients with stable vitiligo—meaning the condition isn't actively spreading—this transplantation led to repigmentation, bringing color back to the skin.

The report describes this as a novel therapeutic option, but it comes with important caveats. We don't know key details like how many patients were treated, how their results compared to other treatments, or exactly how much their skin improved. The type of study, its phase, and specific safety information were also not reported.

This means that while the concept is promising and adds a new tool to the toolbox, it's still an early look. More rigorous research is needed to understand who might benefit most, what the recovery is like, and how the results hold up over time. For now, it represents a hopeful direction in vitiligo care that requires further validation.

What this means for you:
Hair follicle cell transplant shows promise for vitiligo, but details are scarce.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
Vitiligo is an acquired pigmentary disorder of the skin and mucus membranes. Previous study has demonstrated that autologous cultured epithelial grafts (ACEG) is an effective treatment for stable vitiligo. However, extraction of full-thickness skin might result in scar formation at donor site, which have hindered the wider application of this technology, especially for patients requiring large-area transplantation. Hair follicle as a source of keratinocyte and melanocyte, could be potential source of cells for preparation of autologous cultured sheet. Through culture system optimization, we have demonstrated maintenance of undifferentiated hair follicle-derived cells in feeder-independent culture system. After expansion, the hair follicle cells were directed to differentiate into a multi-layered, epidermis-like sheet. Cell identity, viability, purity, genomic stability, and antiseptic testing for hair follicle-derived epithelial sheet (HFES) were evaluated to ensure its safety. Immunofluorescence staining showed that basal keratinocytes were the main cell type of the autologous HFES. Optimization of culture conditions leads to increased melanocyte proliferation and functionality. Transcriptomic analysis confirmed upregulation of melanosome maturation genes. The proportions of cells are also similar to composition of cells under physiological conditions. Transplantation of HFES to depigmented areas in patients with stable vitiligo results in skin repigmentation. This technology provides a novel therapeutic option for vitiligo management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.